Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

Serum Pigment Epithelium-Derived Factor Is Elevated in Women with Polycystic Ovary Syndrome and Correlates with Insulin Resistance

(2011) Shumin Yang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased Serum Levels of Pigment Epithelium-Derived Factor by Excessive Alcohol Consumption-Detection and Identification by a Three-Step Serum Proteome Analysis

(2010) Kazuyuki Sogawa et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Making gene therapy for osteosarcoma a reality

(2010) Matthew L Broadhead et al.   Expert Review of Anticancer Therapy

Circulating Pigment Epithelium-Derived Factor Levels Are Associated with Insulin Resistance and Decrease after Weight Loss

(2010) Mònica Sabater et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A chitosan–dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma

(2009) Hang T. Ta et al.   BIOMATERIALS

A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy

(2009) Hang T. Ta et al.   BIOMATERIALS

The performance of doxorubicin encapsulated in chitosan–dextran sulphate microparticles in an osteosarcoma model

(2009) Mei L. Tan et al.   BIOMATERIALS

In vitroandin vivobiological activity of PEDF against a range of tumors

(2009) Matthew L Broadhead et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Molecular Biology and Therapeutics in Musculoskeletal Oncology*

(2009) Theresa A Guise et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes

(2008) Kazuo Nakamura et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS